Your browser doesn't support javascript.
loading
Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006-2015.
Champeaux Depond, Charles; Zouaoui, Sonia; Darlix, Amélie; Rigau, Valérie; Mathieu-Daudé, Hélène; Bauchet, Fabienne; Khettab, Mohamed; Trétarre, Brigitte; Figarella-Branger, Dominique; Taillandier, Luc; Boetto, Julien; Pallud, Johan; Peyre, Mathieu; Lottin, Marine; Bauchet, Luc.
Affiliation
  • Champeaux Depond C; Department of Neurosurgery, Hôpital Privé Clairval - Ramsay Santé, 317 Bd de Redon, 13009, Marseille, France. Charles.ChampeauxDepond@gmail.com.
  • Zouaoui S; Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier Cedex 5, France.
  • Darlix A; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Rigau V; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Mathieu-Daudé H; Medical Oncology Department, Institut du Cancer de Montpellier, University of Montpellier, 34298, Montpellier, France.
  • Bauchet F; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Khettab M; Department of Pathology, Gui-de-Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier Cedex 5, France.
  • Trétarre B; Department of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier Cedex 5, France.
  • Figarella-Branger D; Department of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier Cedex 5, France.
  • Taillandier L; Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
  • Boetto J; Medical Oncology Unit, CHU de La Réunion, Université de La Réunion, 97410, Saint Pierre, France.
  • Pallud J; Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier Cedex 5, France.
  • Peyre M; APHM, CNRS, INP, Institut de Neurophysiopathologie, CHU Timone, Service d'Anatomie Pathologique Et de Neuropathologie, Aix-Marseille University, 13005, Marseille, France.
  • Lottin M; Department of Neurology, University Hospital of Nancy, Nancy, France.
  • Bauchet L; Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier Cedex 5, France.
Acta Neurochir (Wien) ; 166(1): 320, 2024 Aug 02.
Article in En | MEDLINE | ID: mdl-39093339
ABSTRACT

PURPOSE:

Meningeal solitary fibrous tumour (SFT) and haemangiopericytoma (HPC) are uncommon tumours that have been merged into a single entity in the last 2021 WHO Classification of Tumors of the Central Nervous System. To describe the epidemiology of SFT/HPC operated in France and, to assess their incidence.

METHODS:

We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed SFT/HPC between 2006 and 2015.

RESULTS:

Our study included 399 SFT/HPC patients, operated in France between 2006 and 2015, in one of the 46 participating neurosurgical centres. The incidence reached 0.062, 95%CI[0.056-0.068] for 100,000 person-years. SFT accounted for 35.8% and, HPC for 64.2%. The ratio of SFT/HPC over meningioma operated during the same period was 0.013. SFT/HPC are about equally distributed in women and men (55.9% vs. 44.1%). For the whole population, mean age at surgery was 53.9 (SD ± 15.8) years. The incidence of SFT/HPC surgery increases with the age and, is maximal for the 50-55 years category. Benign SFT/HPC accounted for 65.16%, SFT/HPC of uncertain behaviour for 11.53% and malignant ones for 23.31%. The number of resection progresses as the histopathological behaviour became more aggressive. 6.7% of the patients with a benign SFT/HPC had a second surgery vs.16.6% in case of uncertain behaviour and, 28.4% for malignant SFT/HPC patients.

CONCLUSION:

Meningeal SFT and HPC are rare CNS mesenchymal tumours which both share common epidemiological characteristics, asserting their merging under a common entity. SFT/HPC incidence is less that one case for 1 billion per year and, for around 100 meningiomas-like tumours removed, one SFT/HPC may be diagnosed. SFT/HPC are equally distributed in women and men and, are mainly diagnosed around 50-55 years. The more aggressive the tumour, the higher the probability of recurrence.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Solitary Fibrous Tumors / Hemangiopericytoma / Meningeal Neoplasms Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Acta Neurochir (Wien) Year: 2024 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Solitary Fibrous Tumors / Hemangiopericytoma / Meningeal Neoplasms Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Acta Neurochir (Wien) Year: 2024 Document type: Article Affiliation country: Francia